ESTRO 2024 - Abstract Book

S1522

Clinical - Lower GI

ESTRO 2024

they can identify differences in clinical practice and procedures between centres in different countries. Such audits offer an enormous potential to identify highly efficient practices among the participating institutions. In addition, since the auditors are usually external to the audited centre, they are better able to provide an objective, “fresh outlook” towards the practices and processes at the host institution. Thus, such multi-institutional audits not only pinpoint deviations from standard practice, but they also point to “best practices”, which can then be adopted by all participating centres. Moreover, the published results could also be beneficial to other centres. These preliminary results on patient accrual show a varying case mix of patients at the participating cancer centres. All six centres have enrolled a sufficient number of prostate cancer cases for further analysis, and five of the six centres have accrued a sufficient number of rectal cancer patients. This multi-institutional clinical audit shows considerable variability in clinical practice among the participating centres. Although the clinical indicators showed good adherence to good clinical practice overall, the audit revealed several areas that could be targeted for improvement.

Keywords: radiotherapy; clinical audit; quality indicators

References:

Fundowicz M, Aguiar A, De Castro CL, Torras MG, Deantonio L, Konstanty E, et al. Multicentre clinical radiotherapy audit in rectal cancer: Results of the IROCA project. Radiat Oncol. 2020 Aug 27;15(1):208. Available: https://ro journal.biomedcentral.com/articles/10.1186/s13014-020-01648-7. Lopes de Castro C, Fundowicz M, Roselló A, Jové J, Deantonio L, Aguiar A, et al. Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres. Sci Rep. 10;11(1):1–10. Available from: https://www.nature.com/articles/s41598-021-91723-0. Shortt K, Davidsson L, Hendry J, Dondi M, Andreo P. International Perspectives on Quality Assurance and New Techniques in Radiation Medicine: Outcomes of an IAEA Conference. Int J Radiat Oncol Biol Phys, 2008 May 1;71(1):S80–4.

Scalliet PGM. Clinical radiotherapy audits in Belgium, 2011−2014. Cancer Radiother. 2015;19(6–7):621–3. Available from: https://pubmed.ncbi.nlm.nih.gov/26321683/

Aude V, Yolande L, Pierre S. Feasibility and impact of national peer reviewed clinical audits in radiotherapy departments. Radiother Oncol. 2020, 1;144:218–23.

Vaandering A, Jornet N, Scalliet P, Coffey M, Lievens Y. Doing the right thing: Quality in radiotherapy, a European perspective. Radiother Oncol. 2018;127(2):161–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29548562. Fundowicz M, Macia M, Marin S, Bogusz-Czerniewicz M, Konstanty E, Modolel I, et al. Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland. Radiol Oncol; 2014;48(2):210–8. Available from: http://dx.doi.org/10.2478/raon-2014-0008. Torras MG, Fundowicz M, Aliste L, Asensio E, Boladeras AM, Borràs JM, et al. Improving radiation oncology through clinical audits: Introducing the IROCA project. Rep Pract Oncol Radiother, 2017;22(5):408–14. Available from: https://www.sciencedirect.com/science/article/pii/S1507136716300542.